It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveSeroplasma Biotech Private Limited, a active private limited company, was established on 06 September 2012 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U85191MH2012PTC235383. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rabinder Satpal Chadha (Director), Parmanand Bisham Bhatia (Director). It holds no open charges and ₹2.09 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 29 Krishna Kutir, Plot No. 117-118 Garodia Nagar, Ghatkopar East, Mumbai, Maharashtra, 400077.
U85191MH2012PTC235383
235383
06 September 2012
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Seroplasma Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rabinder Satpal Chadha | Director | 06 Sep 2012 | Current |
| Parmanand Bisham Bhatia | Director | 06 Sep 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seroplasma Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 6598.9% increase. The company also saw a substantial improvement in profitability, with a 1500.39% increase in profit. The company's net worth Soared by an impressive increase of 191.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Seroplasma Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹20,917,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2016 | Hdfc Bank Limited | ₹7.56 M | Satisfied |
| 14 Mar 2013 | The Shamrao Vithal Co Operative Bank Limited | ₹1.34 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Seroplasma Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Seroplasma Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seroplasma Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Seroplasma Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Seroplasma Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on A charge registered on 27 Apr 2016 via Charge ID 100028897 with Hdfc Bank Limited was fully satisfied on 18 Jul 2022. was documented.
A charge registered on 14 Mar 2013 via Charge ID 10419173 with The Shamrao Vithal Co Operative Bank Limited was fully satisfied on 15 May 2017. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.56 M with Charge ID 100028897 was registered on 27 Apr 2016. was documented.
The activity A charge with The Shamrao Vithal Co Operative Bank Limited amounted to Rs. 13.36 M with Charge ID 10419173 was registered on 14 Mar 2013. was completed.
The CIN of Seroplasma Biotech Private Limited is U85191MH2012PTC235383.
Seroplasma Biotech Private Limited is headquartered at 29 Krishna Kutir, Plot No. 117-118 Garodia Nagar, Ghatkopar East, Mumbai, Maharashtra, 400077.
Seroplasma Biotech Private Limited was incorporated on 06 September 2012.
The current directors of Seroplasma Biotech Private Limited are
The primary industry of Seroplasma Biotech Private Limited is Manufacturing.
Seroplasma Biotech Private Limited is unlisted.
The authorized capital of Seroplasma Biotech Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Seroplasma Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX